Colmenero J D, Jiménez-Mejías M E, Sánchez-Lora F J, Reguera J M, Palomino-Nicás J, Martos F, García de las Heras J, Pachón J
Unit of Infectious Diseases, University Regional Hospital Carlos Haya, Málaga, Spain.
Ann Rheum Dis. 1997 Dec;56(12):709-15. doi: 10.1136/ard.56.12.709.
To describe a large series of patients with vertebral osteomyelitis (VO), and to compare the clinical, biological, radiological, and prognostic features of pyogenic (PVO), tuberculous (TVO), and brucellar vertebral osteomyelitis (BVO).
A retrospective multicentre study, which included 219 adult patients with VO with confirmed aetiology, who were diagnosed between 1983 and 1995 in two tertiary care centres. Of these patients, 105 (48%) had BVO, 72 (33%) PVO, and 42 (19%) TVO.
One hundred and forty eight (67.6%) patients were male and 71 (32.4%) female. The mean (SD) age was 50.4 (16.4) years (range 14-84) and the mean (SD) duration of symptoms before the diagnosis was 14 (16.8) weeks. In 127 patients (57.9%) the vertebral level involved was lumbar, in 70 (31.9%) thoracic, and in 16 (7.3%) cervical. One hundred and nineteen patients (54.4%) received only medical treatment and 100 (45.6%) required both medical and surgical treatment. The presence of diabetes mellitus, intravenous drug abuse, underlying chronic debilitating diseases or immunosuppression, previous infections, preceding bacteraemia, recent vertebral surgery, leucocytosis, neutrophilia, and increased erythrocyte sedimentation rate (ESR) were significantly associated to PVO. A prolonged clinical course, thoracic segment involvement, absence of fever, presence of spinal deformity, neurological deficit, and paravertebral or epidural masses, were significantly more frequent in the group of TVO. The need for surgical treatment and the presence of severe functional sequelae were more frequent in the groups of PVO and TVO.
There are significant clinical, biological, radiological, and prognostic differences between BVO, PVO, and TVO. These differences can point to the causal agent and orient the initial empirical medical treatment while awaiting a final microbiological diagnosis.
描述一大组椎体骨髓炎(VO)患者,并比较化脓性(PVO)、结核性(TVO)和布鲁氏菌性椎体骨髓炎(BVO)的临床、生物学、放射学及预后特征。
一项回顾性多中心研究,纳入1983年至1995年期间在两家三级医疗中心确诊病因的219例成年VO患者。其中,105例(48%)为BVO,72例(33%)为PVO,42例(19%)为TVO。
148例(67.6%)患者为男性,71例(32.4%)为女性。平均(标准差)年龄为50.4(16.4)岁(范围14 - 84岁),诊断前症状的平均(标准差)持续时间为14(16.8)周。127例(57.9%)患者受累椎体节段为腰椎,70例(31.9%)为胸椎,16例(7.3%)为颈椎。119例(54.4%)患者仅接受药物治疗,100例(45.6%)患者需要药物和手术治疗。糖尿病、静脉药物滥用、潜在慢性衰弱性疾病或免疫抑制、既往感染、先前菌血症、近期椎体手术、白细胞增多、中性粒细胞增多以及红细胞沉降率(ESR)升高与PVO显著相关。TVO组临床病程延长、胸椎节段受累、无发热、存在脊柱畸形、神经功能缺损以及椎旁或硬膜外肿块更为常见。PVO组和TVO组手术治疗需求及严重功能后遗症更为常见。
BVO、PVO和TVO之间在临床、生物学、放射学及预后方面存在显著差异。这些差异可提示病原体,并在等待最终微生物学诊断期间指导初始经验性药物治疗。